Effectiveness of Community-Wide and Individual High-Risk Strategies to Prevent Diabetes: A Modelling Study

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Manuel, Douglas G ^a,b,c,d   Rosella, Laura C ^c,d,e   Tuna, Meltem ^a,c   Bennett, Carol ^a,c   Stukel, Thérèse A ^c,d  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e PUBLIC HEALTH ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; ARTICLE; BODY MASS; CANADA; COMMUNITY PROGRAM; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COUNSELING; RISK ASSESSMENT; RISK REDUCTION; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ONTARIO; PUBLIC HEALTH; RISK FACTORS; YOUNG ADULT;

EID: 84871882409     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052963     Document Type: Article

References (27)

1. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, et al. (2005) A potential decline in life expectancy in the United States in the 21st century. New England Journal of Medicine 352: 1138-1145.
2. Paulweber B, Valensi P, Lindstrom J, Lalic NM, Greaves CJ, et al. (2010) A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 42 (Suppl 1):: S3-36.
3. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, et al. (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334: 299.
4. Rose GA (1992) The strategy of preventive medicine. Oxford; New York: Oxford University Press. xii, 138 p.
5. Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, et al. (2006) Revisiting Rose: strategies for reducing coronary heart disease. British Medical Journal 332: 659-662.
6. Jain A, (2005) Treating obesity in individuals and populations. BMJ 331: 1387-1390.
7. Swinburn B, Gill T, Kumanyika S, (2005) Obesity prevention: a proposed framework for translating evidence into action. Obes Rev 6: 23-33.
8. Gortmaker SL, Swinburn BA, Levy D, Carter R, Mabry PL, et al. (2011) Changing the future of obesity: science, policy, and action. The Lancet 378: 838-847.
9. Rosella LC, Manuel DG, Burchill C, Stukel TA, (2011) A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). Journal of Epidemiology and Community Health 65: 613-620.
10. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T, (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343: d7163.
11. Collins GS, Mallett S, Omar O, Yu LM, (2011) Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 9: 103.
12. Branca F, Nikogosian H, Lobstein T (2007) The challenge of Obesity in the WHO European Region and the Strategies for Response: Summary: World Health Organization.
13. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, et al. (2011) Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 183: 1007-1013.
14. Katzmarzyk PT, Craig CL, Bouchard C, (2001) Original Article Underweight, overweight and obesity: relationships with mortality in the 13-year follow-up of the Canada Fitness Survey. Journal of Clinical Epidemiology 54: 916-920.
15. World Health Organization (2000) Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organization.
16. Rose G, (2001) Sick individuals and sick populations. 1985. Bulletin of the World Health Organization 79: 990-996.
17. Rush B, Shiell A, Hawe P (2002) A Census of Economic Evaluations of Primary Prevention Interventions in Population Health. Calgary: University of Calgary. 1-39 p.
18. Goldsmith L, Hutchison B, Hurley J (2004) Economic evaluation across the four faces of prevention: a Canadian perspective. McMaster University, Centre for Health Economics and Policy Analysis.
19. Bertram MY, Lim SS, Barendregt JJ, Vos T, (2010) Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care. Diabetologia 53: 875-881.
20. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, et al. (2008) Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 336: 1180-1185.
21. Drummond MF, O'Brien B, Stoddart GL, Torrance DL (1997) Methods for the Economic Evaluation of Health Care Programs. Toronto: Oxford University Press. 1-305 p.
22. Canadian Agency for Drugs and Technologies in Health (2006) Guidelines for the economic evaluation of health technologies: Canada [3rd Edition]. Available: http://www.cadth.ca/media/pdf/186_EconomicGuidelines_e.pdf. Accessed 07 December 2012.
23. Haby MM, Vos T, Carter R, Moodie M, Markwick A, et al. (2006) A new approach to assessing the health benefit from obesity interventions in children and adolescents: the assessing cost-effectiveness in obesity project. Int J Obes (Lond) 30: 1463-1475.
24. McLaren L, McIntyre L, Kirkpatrick S, (2010) Rose's population strategy of prevention need not increase social inequalities in health. International Journal of Epidemiology 39: 372-377.
25. Lindstrom J, Absetz P, Hemio K, Peltomaki P, Peltonen M, (2010) Reducing the risk of type 2 diabetes with nutrition and physical activity- efficacy and implementation of lifestyle interventions in Finland. Public Health Nutr 13: 993-999.
26. Manuel DG, Rosella LC, (2010) Commentary: assessing population (baseline) risk is a cornerstone of population health planning-looking forward to address new challenges. Int J Epidemiol 39: 380-382.
27. Rose G, (1991) Environmental health: problems and prospects. Journal of the Royal College of Physicians of London 25: 48-52.